HIV or AIDS Diagnostics

HIV or AIDS Diagnostics Market by Product Type (Instruments, Kits & Reagents), Test Type (ELISA, Nucleic Acid Tests, Rapid Tests), End User - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the hiv or aids diagnostics market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[197 Pages Report] The HIV or AIDS Diagnostics Market size was estimated at USD 6.84 billion in 2023 and expected to reach USD 7.46 billion in 2024, at a CAGR 9.12% to reach USD 12.62 billion by 2030.

HIV or AIDS Diagnostics Market
To learn more about this report, request a free PDF copy
HIV or AIDS Diagnostics Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the HIV or AIDS Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the HIV or AIDS Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the HIV or AIDS Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alere Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Chembio Diagnostic Systems Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., OraSure Technologies, Inc., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the HIV or AIDS Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Instruments
    • Kits & Reagents
  • Test Type
    • ELISA
    • Nucleic Acid Tests
    • Rapid Tests
  • End User
    • Academic & Research Institutes
    • Hospitals
    • Private Diagnostics Laboratories

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the HIV or AIDS Diagnostics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the HIV or AIDS Diagnostics Market?
  3. What are the technology trends and regulatory frameworks in the HIV or AIDS Diagnostics Market?
  4. What is the market share of the leading vendors in the HIV or AIDS Diagnostics Market?
  5. Which modes and strategic moves are suitable for entering the HIV or AIDS Diagnostics Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. HIV or AIDS Diagnostics Market, by Product Type
  7. HIV or AIDS Diagnostics Market, by Test Type
  8. HIV or AIDS Diagnostics Market, by End User
  9. Americas HIV or AIDS Diagnostics Market
  10. Asia-Pacific HIV or AIDS Diagnostics Market
  11. Europe, Middle East & Africa HIV or AIDS Diagnostics Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 284]
  16. List of Companies Mentioned [Total: 10]
Newfangled Diagnostic Tests To Be HIV And AIDS Positives' Shining Saviour
April 11, 2023
INSIGHT
Newfangled Diagnostic Tests To Be HIV And AIDS Positives' Shining Saviour
New diagnostics have emerged as a promising way to pinpoint HIV and AIDS positives in the early detection of the ailment and notify the patients to prevent the contagion of the disease.

The primary causes of the global burden of disease are the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). Around 650,000 persons globally passed away from AIDS-related illnesses in 2021, according to the Minority HIV/AIDS Fund.

To control this growing burden, WHO is engaged in aiding the adoption, expansion, and accessibility of HIV testing and diagnostic technologies nationally and internationally. The Global Fund to Fight AIDS also funded USD 24.2 billion in programs to prevent HIV and AIDS, making up 30% of all international funding for HIV programs.

New treatment options are being explored using advanced diagnostic techniques to lower the number of HIV and AIDS cases. The diagnosis of HIV has significantly improved thanks to methods such as Polymerase Chain Reaction (PCR), rapid testing, enzyme immunoassay (EIA), p24 antigen, and western blot.

To assist patients in overcoming the stigma around HIV testing, businesses are introducing HIV self-tests that are readily available in medical stores. Abbott Laboratories introduced the Panbio HIV Self Test in November 2022 for over-the-counter purchases through eCommerce platforms enabling consumers to receive results whenever they are willing, anywhere, in 15 to 20 minutes.

With adequate financial support from governments globally and advancements in HIV and AIDS, diagnostics and testing methods support patients to easily diagnose the condition and help reduce the transmission of this disease.

Frequently Asked Questions
  1. How big is the HIV or AIDS Diagnostics Market?
    Ans. The Global HIV or AIDS Diagnostics Market size was estimated at USD 6.84 billion in 2023 and expected to reach USD 7.46 billion in 2024.
  2. What is the HIV or AIDS Diagnostics Market growth?
    Ans. The Global HIV or AIDS Diagnostics Market to grow USD 12.62 billion by 2030, at a CAGR of 9.12%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.